The study found that multinational companies are producing antibiotics and not selling them in India.
Analysts from the London University of Queens and Newcastle University have published the results. Accordingly, FDC Antibiotic Formulas, which are available in the same tablet for sale in India, sold 2 or more drugs from 2007 to 2012.
64 percent of the drug formulas are not recognized by the Central Pharmaceutical Quality Assurance Company. According to these formulas, more than 500 companies, including multinational companies, have produced and sold drugs in 3 thousand and 300 business names. Analysts have shown that the preparation of anti-inflammatory drugs is a major challenge to the development of anti-inflammatory drugs without controlling the antibiotics.